I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Supko, Jeffrey G
94
results:
Search for persons
X
Format
Online (94)
Mediatypes
Articles (Online) (88)
Bookchapter (Online) (2)
OpenAccess-fulltext (4)
Sorted by: Relevance
Sorted by: Year
?
1
A Phase I Study of Pelabresib (CPI-0610), a Small-Molecule ..:
Blum, Kristie A.
;
Supko, Jeffrey G.
;
Maris, Michael B.
...
Cancer Research Communications. 2 (2022) 8 - p. 795-805 , 2022
Link:
https://doi.org/10.1158/..
?
2
Multimodal platform for assessing drug distribution and res..:
Lopez, Begoña G C
;
Kohale, Ishwar N
;
Du, Ziming
...
Neuro-Oncology. 24 (2021) 1 - p. 64-77 , 2021
Link:
https://doi.org/10.1093/..
?
3
Targeting constitutively active STAT3 in chronic lymphocyti..:
Brown, Jennifer R.
;
Walker, Sarah R.
;
Heppler, Lisa N.
...
American Journal of Hematology. 96 (2021) 4 - p. , 2021
Link:
https://doi.org/10.1002/..
?
4
Phase 1b clinical trial of ado-trastuzumab emtansine and ri..:
Spring, Laura M.
;
Clark, Shealagh L.
;
Li, Tianyu
...
npj Breast Cancer. 7 (2021) 1 - p. , 2021
Link:
https://doi.org/10.1038/..
?
5
Combined PARP and HSP90 inhibition: preclinical and Phase 1..:
Konstantinopoulos, Panagiotis A.
;
Cheng, Su-Chun
;
Supko, Jeffrey G.
...
British Journal of Cancer. 126 (2021) 7 - p. 1027-1036 , 2021
Link:
https://doi.org/10.1038/..
?
6
Phase 1 study of the HSP90 inhibitor onalespib in combinati..:
Do, Khanh T.
;
O'Sullivan Coyne, Geraldine
;
Hays, John L.
...
Cancer Chemotherapy and Pharmacology. 86 (2020) 6 - p. 815-827 , 2020
Link:
https://doi.org/10.1007/..
?
7
Blood-brain barrier disruption and delivery of irinotecan i..:
McDannold, Nathan
;
Zhang, Yongzhi
;
Supko, Jeffrey G.
...
Scientific Reports. 10 (2020) 1 - p. , 2020
Link:
https://doi.org/10.1038/..
?
8
Acoustic feedback enables safe and reliable carboplatin del..:
McDannold, Nathan
;
Zhang, Yongzhi
;
Supko, Jeffrey G.
...
Theranostics. 9 (2019) 21 - p. 6284-6299 , 2019
Link:
https://doi.org/10.7150/..
?
9
A dose finding clinical trial of cabozantinib (XL184) admin..:
Choudhury, Atish D.
;
Gray, Kathryn P.
;
Supko, Jeffrey G.
...
The Prostate. 78 (2018) 14 - p. 1053-1062 , 2018
Link:
https://doi.org/10.1002/..
?
10
Timed sequential therapy of the selective T-type calcium ch..:
Holdhoff, Matthias
;
Ye, Xiaobu
;
Supko, Jeffrey G.
...
Neuro-Oncology. 19 (2017) 6 - p. 845-852 , 2017
Link:
https://doi.org/10.1093/..
?
11
Feasibility, phase I, and phase II studies of tandutinib, a..:
Batchelor, Tracy T.
;
Gerstner, Elizabeth R.
;
Ye, Xiaobu
...
Neuro-Oncology. , 2016
Link:
https://doi.org/10.1093/..
?
12
Phase I study of RO4929097 with bevacizumab in patients wit..:
Pan, Edward
;
Supko, Jeffrey G.
;
Kaley, Thomas J.
...
Journal of Neuro-Oncology. 130 (2016) 3 - p. 571-579 , 2016
Link:
https://doi.org/10.1007/..
?
13
Phase I study of iniparib concurrent with monthly or contin..:
Blakeley, Jaishri O.
;
Grossman, Stuart A.
;
Mikkelsen, Tom
...
Journal of Neuro-Oncology. 125 (2015) 1 - p. 123-131 , 2015
Link:
https://doi.org/10.1007/..
?
14
A phase I/II trial of hydroxychloroquine in conjunction wit..:
Rosenfeld, Myrna R
;
Ye, Xiaobu
;
Supko, Jeffrey G
...
Autophagy. 10 (2014) 8 - p. 1359-1368 , 2014
Link:
https://doi.org/10.4161/..
?
15
Multicenter Phase II Study of Tivozanib (AV-951) and Everol..:
Wolpin, Brian M.
;
Ng, Kimmie
;
Zhu, Andrew X.
...
The Oncologist. 18 (2013) 4 - p. 377-378 , 2013
Link:
https://doi.org/10.1634/..
1-15